GI Innovation allergic diseases treatment
Scope
Date
~
-
Bio & Pharma
Celltrion to deliver three treatments to Peru
South Korea’s Celltrion Inc. announced on Thursday that it will supply three treatments, including its blood cancer drug Truxima (rituximab) t...
Feb 15, 2024 (Gmt+09:00)
-
Korean Investors
Samsung Asset to launch S.Korea's first obesity treatment ETF
Korea Exchange announced on Thursday that it will list Samsung Asset Management's "KODEX Global Obesity Treatment Top 2 Plus exchange-traded fund (E...
Feb 08, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to supply Remsima SC, Yuflyma to Norway
South Korea's Celltrion Inc. announced on Wednesday that it will supply its autoimmune disease treatments Remsima SC (infliximab) and Yuflyma, the...
Feb 07, 2024 (Gmt+09:00)
-
Bio & Pharma
Aprogen gets OK Phase 3 trials in India for Herceptin biosimilar
South Korea’s biopharmaceutical company Aprogen Inc. announced on Monday that its Phase 3 clinical trial for a biosimilar of Herceptin (trastu...
Feb 05, 2024 (Gmt+09:00)
-
Bio & Pharma
Kakao launches AI-based blood sugar management solution
South Korea’s Kakao Healthcare Corp. has introduced an artificial intelligence-based blood sugar management solution targeting the global digi...
Feb 01, 2024 (Gmt+09:00)
-
Artificial intelligence
LG CNS launches AI center for synergy of business, research
South Korea’s LG CNS Co., a cloud computing services arm of LG Corp., said on Sunday it has launched an artificial intelligence center to stre...
Jan 21, 2024 (Gmt+09:00)
-
Bio & Pharma
Kobiolabs gets Chinese patent for obesity treatment strain
South Korean microbiome-based new drug development company Kobiolabs Co. announced on Wednesday that it has a patent for its obesity treatment strai...
Jan 17, 2024 (Gmt+09:00)
-
Bio & Pharma
Kobiolabs gets US patent for oral obesity drug candidate
Kobiolabs Co., a South Korean microbiome-based new drug development company, announced on Wednesday that it has a patent for Roseburia intestinalis ...
Jan 10, 2024 (Gmt+09:00)
-
Bio & Pharma
Inventage Lab, Yuhan to co-work for obesity treatment
South Korea’s Inventage Lab Inc. announced on Friday that it has signed a joint development agreement with Yuhan Corp. for a long-acting inj...
Jan 05, 2024 (Gmt+09:00)
-
Banking & Finance
Korea's KDB establishes innovation fund for auto parts companies
The state-run Korea Development Bank (KDB) announced on Friday that it has established the KDB-Quantum Mobility Value Chain Open Innovation Fund wor...
Dec 29, 2023 (Gmt+09:00)
-
Bio & Pharma
ViGenCell, NK/T cell lymphoma treatment ‘VT-EBV-N’ designated as orphan drug in Europe
ViGenCell, a company specializing in immune cell therapy, announced on the 19th that its NK/T cell lymphoma treatment "VT-EBV-N" has been designated...
Dec 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval of Xolair biosimilar in Canada
South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has applied for CT-P39, a biosimilar of the treatment of asth...
Dec 27, 2023 (Gmt+09:00)
-
Artificial intelligence
HD Hyundai, Google Cloud team up to accelerate generative AI innovation
HD Hyundai Co., South Korea’s shipbuilding-to-heavy machinery conglomerate, said on Tuesday it has teamed up with Google Cloud, the informatio...
Dec 26, 2023 (Gmt+09:00)
-
Bio & Pharma
ToolGen gets FDA approval for TGT-001 as ODD
South Korean genome editing developer ToolGen Inc. announced on Monday that its application for orphan drug designation (ODD) of the gene correction...
Dec 18, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
LG Electronics launches AI-powered LG Gram laptop
South Korean electronics giant LG Electronics Inc. announced on Friday its plans to launch the AI-powered LG Gram laptop, featuring Intel's next-gen...
Dec 15, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea’s GC Cell targets global cell therapy CDMO business
GC Cell Corp., an affiliate of South Korea’s major pharmaceutical company GC Biopharma Corp., is targeting the cell therapy contract developme...
Dec 12, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Vegzelma listed on US PBM preferred drug list
South Korea's Celltrion Healthcare Co. announced on Tuesday that its anti-cancer biosimilar Vegzelma (active ingredient: bevacizumab) was listed as ...
Dec 12, 2023 (Gmt+09:00)
-
Chemical Industry
Samyang launches industrial water treatment products
South Korean chemical and food company Samyang Corp. announced on Monday that it released new industrial water treatment materials Triraite Reverse ...
Dec 11, 2023 (Gmt+09:00)
-
Batteries
LG Energy, KAIST develop Li-Metal battery tech for improved EV range
South Korea’s LG Energy Solution Ltd. and the Korea Advanced Institute of Science & Technology (KAIST) have developed a lithium-metal batt...
Dec 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare's Herzuma selected as funded brand in NZ
Celltrion Healthcare Co. announced on Thursday that its biosimilar anticancer drug Herzuma (active ingredient trastuzumab) for breast and gastr...
Dec 07, 2023 (Gmt+09:00)
-
Cryptocurrencies
WeMade to build WEMIX Play Center in Dubai
South Korea’s game developer and publisher WeMade Co. announced on Wednesday that it partnered with the Dubai International Financial Center's...
Dec 06, 2023 (Gmt+09:00)
-
Automobiles
Hyundai Mobis builds new electrification research center
South Korea’s Hyundai Mobis announced on Tuesday that it opened the Electrification Research Center in Euiwang, Gyeonggi Province, South Korea...
Dec 05, 2023 (Gmt+09:00)
-
Executive reshuffles
SK Chair Chey calls on cousin for help in group management
SK Group Chairman Chey Tae-won has called on his cousin to help in the management of South Korea’s No. 2 conglomerate as it faces the challeng...
Dec 05, 2023 (Gmt+09:00)
-
Automobiles
Hyundai Mobis unveils world’s first QL display for vehicles
South Korea’s top auto parts maker Hyundai Mobis Co. said on Thursday it has developed an innovative premium display for vehicles – the ...
Nov 30, 2023 (Gmt+09:00)
-
Korean startups
KOTRA to support K-startups in European expansion
The Korea Trade-Investment Promotion Agency (KOTRA) announced on Wednesday the establishment of a South Korean pavilion at the upcoming SLUSH 2023, ...
Nov 29, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval in Europe for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it applied for approval from the European Medicines Agency (EMA) for ...
Nov 24, 2023 (Gmt+09:00)
-
Bio & Pharma
SK C&C to promote AI healthcare for brain diseases
South Korea's SK C&C announced on Thursday that it signed a strategic business agreement with Neurophet, a cloud-based AI platform for brain ima...
Nov 23, 2023 (Gmt+09:00)
-
Automobiles
Hyundai ushers in future of car manufacturing in Singapore
SINGAPORE – Hyundai Motor Group on Tuesday officially inaugurated its first mobility innovation center in Singapore powered by a slew of smart...
Nov 21, 2023 (Gmt+09:00)
-
Bio & Pharma
South Korean bio, pharma industry set to take leap
South Korea’s chemical maker LG Chem Ltd. is expected to reap more than 1 trillion won ($768.5 million) in sales this year from its new growth...
Nov 15, 2023 (Gmt+09:00)
-
Bio & Pharma
'World-class bispecific antibody technology of ABL Bio'
MADRID - "The clinical Phase 1 results of the immune-oncology candidate ABL111, developed in collaboration with ABL Bio, have been selected as the b...
Nov 13, 2023 (Gmt+09:00)